President and Chief Executive Officer since 2018, Rohan Hastie has helped usher North Carolina-based firm Metabolon into a new era of success in the fields of precision medicine and clinical metabolomics.
MORRISVILLE, N.C. – May 17, 2021 – Rohan F. Hastie, Ph.D., President & CEO, Metabolon, Inc. has been recognized as one of the top 50 healthcare technology CEOs for 2021 by The Healthcare Technology Report. The ranking includes leaders who are driving cutting-edge technologies and unique opportunities for transformative growth within their areas of expertise.
Dr. Hastie has been at the helm of Metabolon since 2018, when initiated the company’s efforts to dramatically expand awareness and application of metabolomics in the biopharma market, setting a vision of enlightening life and enabling a healthier world. Under Dr. Hastie’s leadership, the company as expanded its commercial client base and secured significant investor funding to fuel new R&D programs in machine learning, novel biomarker discovery and an expanded precision medicine platform. Metabolon continues to demonstrate to researchers how metabolomics can be performed at scale with precision and quality assurance to support biopharma throughout the drug development continuum.
“At Metabolon, we are leveraging all of our talents and capabilities to become a diversified leader in healthcare and enable our clients to make important scientific breakthroughs,” says Hastie. “Metabolomics is a valuable tool that supports researchers in understanding internal and external factors of disease to improve the health and well-being of people.”